Suzhou, China

Qi Zhao

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Beijing Pharbers Genesis Pharm-Tech Co., Ltd., Je & Na Biotech. Co., Ltd., Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qi Zhao. Retrieved from https://idiyas.com/inventor/qi-zhao-jda3u3mv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Qi Zhao

Introduction

Qi Zhao is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in cancer therapy. With a total of 3 patents, his work focuses on innovative compositions and methods for treating tumors.

Latest Patents

Qi Zhao's latest patents include a composition comprising catalase, a preparation method, and its use in killing tumor cells. This composition utilizes a radionuclide labeled to a biomacromolecule, a soluble alginate, and catalase. The method allows for the injection of the composition into tumors through interventional treatment. Upon encountering calcium ions, a gel is formed, which helps confine the radionuclide and catalase uniformly within the tumor. The catalase decomposes dissolved oxygen generated from hydrogen peroxide, advancing the hypoxic state of tumor cells, which can then be effectively targeted with radiation. This innovative approach shows promising prospects for applications in cancer therapy.

Another significant patent by Qi Zhao involves PD-L1 binding polypeptides and their uses in detecting and diagnosing PD-L1 related diseases, including various cancers. This invention highlights his commitment to advancing medical technology and improving patient outcomes.

Career Highlights

Throughout his career, Qi Zhao has worked with several companies, including Suzhou Smartnuclide Biopharmaceutical Co., Ltd. and Je & Na Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.

Collaborations

Qi Zhao has collaborated with notable professionals in his field, including Zhuang Liu and Kai Yang. These partnerships have further enhanced his research and development efforts in biomedicine.

Conclusion

In summary, Qi Zhao is a distinguished inventor whose work in biomedicine, particularly in cancer treatment, has led to significant innovations. His patents reflect a deep understanding of the complexities of tumor treatment and showcase his dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…